These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6324161)
21. Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results. Hellriegel KP; Kindler J; Wittenberg C; Kress M Infection; 1982; 10 Suppl 3():S138-40. PubMed ID: 6218101 [TBL] [Abstract][Full Text] [Related]
22. Review of amikacin usage in the EORTC trials. Zinner SH Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903 [TBL] [Abstract][Full Text] [Related]
23. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis]. Grenier B; Gilly R Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602 [TBL] [Abstract][Full Text] [Related]
24. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269 [TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602 [TBL] [Abstract][Full Text] [Related]
26. Comparison of two versus three daily infusions of cefotaxime plus amikacin in granulocytopenic children. Vannier JP; Gardembas-Pain M; Blaysat G; Lemeland JF; Tron P Drugs; 1988; 35 Suppl 2():231. PubMed ID: 3396486 [No Abstract] [Full Text] [Related]
27. In vitro considerations in monotherapy and combination therapy for severe infections. Gaya H Am J Med; 1986 May; 80(5C):75-8. PubMed ID: 3717192 [TBL] [Abstract][Full Text] [Related]
28. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies. Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402 [TBL] [Abstract][Full Text] [Related]
29. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. ; Calandra T; Klastersky J; Gaya H; Glauser MP; Meunier F; Zinner SH N Engl J Med; 1987 Dec; 317(27):1692-8. PubMed ID: 2892130 [TBL] [Abstract][Full Text] [Related]
31. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044 [TBL] [Abstract][Full Text] [Related]
32. Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients. Mergoni M; Stocchetti N; De Cristofaro A; Antonioni M; Zuccoli P Chemioterapia; 1987 Aug; 6(4):286-9. PubMed ID: 3652280 [TBL] [Abstract][Full Text] [Related]
33. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group. Gaya H Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992 [TBL] [Abstract][Full Text] [Related]
34. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228 [TBL] [Abstract][Full Text] [Related]
35. [Combined chemotherapy of experimental infection in neutropenia]. Viadro MM; Ivanitskaia LP; Samoĭlova LN; Kudinova MK; Bodunkova LE Antibiot Khimioter; 1989 May; 34(5):378-82. PubMed ID: 2662929 [TBL] [Abstract][Full Text] [Related]
36. Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients. Finley RS; Fortner CL; deJongh CA; Wade JC; Newman KA; Caplan E; Britten J; Wiernik PH; Schimpff SC Antimicrob Agents Chemother; 1982 Aug; 22(2):193-7. PubMed ID: 6765414 [TBL] [Abstract][Full Text] [Related]
37. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units]. Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273 [TBL] [Abstract][Full Text] [Related]
38. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study. Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)]. Yamaguchi H; Ichimaru M Jpn J Antibiot; 1980 Nov; 33(11):1215-22. PubMed ID: 7241796 [No Abstract] [Full Text] [Related]
40. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections. Cox CE J Antimicrob Chemother; 1983 May; 11 Suppl B():183-8. PubMed ID: 6352601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]